Table 1 Expression of BCL-6, Phenotypic Markers, and Relationship to the BCL-6 Gene Structural Alterations in T-NHLs
Case | Diagnosis | BCL-6 | CD30 | CD4 | CD8 | SSCP | SB |
|---|---|---|---|---|---|---|---|
1 | LBL | # | − | − | + | WT | G |
2 | LBL | − | − | − | + | WT | G |
3 | LBL | 20–30% | − | ND | ND | WT | G |
4 | LBL | 20% | − | + | + | WT | G |
5 | LBL | 30% | − | + | + | WT | G |
6 | LBL | − | − | + | ♦ | WT | G |
7 | LBL | # | − | + | − | WT | G |
8 | LBL | − | − | + | − | WT | G |
9 | ALCL | 60% | + | − | + | WT | G |
10 | ALCL | 30% | + | + | − | WT | G |
11 | ALCL | 30% | + | + | − | WT | G |
12 | ALCL | 20% | + | + | ♦ | WT | G |
13 | ALCL | − | + | − | + | WT | G |
14 | ALCL | # | + | + | ♦ | WT | G |
15 | ALCL | # | + | + | − | WT | G |
16 | ALCL | # | + | ND | ND | WT | G |
17 | ALCL | # | + | + | − | WT | G |
18 | ALCL | # | + | − | + | WT | G |
19 | IBL | 20% | − | + | + | WT | G |
20 | IBL | # | − | + | − | M (E1.11.) | G |
21 | PTCL | 40% | − | + | ♦ | WT | G |
22 | PTCL | # | − | − | + | WT | G |
23 | PTCL | # | ND | ND | ND | WT | G |
24 | PTCL | # | − | + | − | WT | G |
25 | PTCL | # | ND | ND | ND | WT | G |
26 | PTCL | # | ♦ | + | − | M (E1.12.) | G |
27 | PTCL | 20% | − | + | − | M (E1.11.) | G |
28 | PTCL | 20% | ND | + | − | WT | G |
29 | PTCL | − | − | + | ♦ | WT | G |
30 | PTCL | # | − | + | − | WT | G |
31 | AILD | 20% | − | + | − | WT | G |
32 | AILD | − | − | + | − | WT | G |
33 | MF | ND | − | + | − | WT | G |
